Table 1 Patient, surgery and tumor characteristics, reported as n(%), or median[IQR]
Total (n = 60) | Saline (n = 28) | Taurolidine (n = 32) | p-value | |
|---|---|---|---|---|
Sex | ||||
F | 21 (35%) | 6 (21.4%) | 15 (46.9%) | 0.07 |
M | 39 (65%) | 22 (78.6%) | 17 (53.1%) | |
Age | 69 [59.8, 72.2] | 67 [58.8, 72] | 69.5 [65.2, 72.2] | 0.49 |
Surgery | ||||
Anterior resection | 27 (45%) | 12 (42.8%) | 15 (55.6%) | 0.55 |
Right hemicolectomy | 23 (38.3%) | 12 (42.8%) | 11 (40.7%) | |
Total colectomy | 1 (1.7%) | 0(0%) | 1 (3.7%) | |
Other | 9 (15%) | 4 (14.2%) | 5 (15.6%) | |
Procedure | ||||
Converted | 6 (10%) | 3 (10.7%) | 3 (9.4%) | 0.59 |
Lap | 47 (78.3%) | 23 (82.1%) | 24 (75%) | |
Open | 7 (11.7%) | 2 (7.1%) | 5 (15.6%) | |
Primary tumor | ||||
T1 | 4 (6.7%) | 1 (3.6%) | 3 (9.3%) | 0.59 |
T2 | 8 (13.3%) | 5 (17.8%) | 3 (9.3%) | |
T3 | 34 (56.6%) | 16 (57.1%) | 18 (56.2%) | |
T4 | 8 (13.3%) | 2 (7.1%) | 6 (18.8%) | |
T4a | 4 (6.7%) | 3 (10.7%) | 1 (3.2%) | |
T4b | 1 (1.7%) | 1 (3.5%) | 0 (0%) | |
Carcinoid | 1 (1.7%) | 0 (0%) | 1 (3.2%) | |
Regional lymph nodes | ||||
N0 | 31 (51.6%) | 12 (42.8%) | 19 (59.4%) | 0.37 |
N1 | 9 (15%) | 5 (17.8%) | 4 (12.5%) | |
N1a | 7 (11.6%) | 4 (14.2%) | 3 (9.4%) | |
N1b | 6 (10.0%) | 3 (10.8%) | 3 (9.4%) | |
N2 | 5 (8.4%) | 3 (10.8%) | 2 (6.2%) | |
N2b | 2 (3.4%) | 1 (3.6%) | 1 (3.1%) | |
Lymph node yield | 17 | 16 | 18 | 0.58 |
Follow-up (months) | 34 | 32 | 37 | 0.23 |